Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

11 Jun 2026 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg. The Company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1802.80
Dr. Reddys Labs. 1355.15
Cipla 1377.50
Lupin 2011.20
Zydus Lifesciences 1235.90
View more..